Begin typing your search...

Dash Pharma takeover complete: Natco

City-based Natco Pharma announced its wholly - owned subsidiary Natco Pharma Inc completed the acquisition of US based Dash Pharmaceuticals LLC for $18mn (Rs 135 crore).

image for illustrative purpose

Dash Pharma takeover complete: Natco
X

3 Jan 2022 12:02 AM IST

Hyderabad: City-based Natco Pharma announced its wholly - owned subsidiary Natco Pharma Inc completed the acquisition of US based Dash Pharmaceuticals LLC for $18mn (Rs 135 crore).

Dash organises front-end pharma sales, marketing and distribution in the USA. Natco revealed to the exchanges that Dash Pharma could register approximately $15mn sales for the financial year ending December 2021.

Dash had net revenue of $11.13mn for the financial year ended December 31, 2020, the company said.

Dash Pharma Natco Hyderabad 
Next Story
Share it